Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in medical wards remains unknown. Objectives: To evaluate the effects of intermediate-dose vs. standard-dose prophylactic anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Smadja, David M., Bonnet, Guillaume, Gendron, Nicolas, Weizman, Orianne, Khider, Lina, Trimaille, Antonin, Mirault, Tristan, Fauvel, Charles, Diehl, Jean-Luc, Mika, Delphine, Philippe, Aurelien, Pezel, Théo, Goudot, Guillaume, Sutter, Willy, Planquette, Benjamin, Waldmann, Victor, Sanchez, Olivier, Cohen, Ariel, Chocron, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553987/
https://www.ncbi.nlm.nih.gov/pubmed/34722585
http://dx.doi.org/10.3389/fmed.2021.747527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553987/
https://www.ncbi.nlm.nih.gov/pubmed/34722585
http://dx.doi.org/10.3389/fmed.2021.747527

Ejemplares similares